Report Templates Available for EasyOne Pro (LAB) and Easy on-pc

Similar documents
Content Indica c tion Lung v olumes e & Lung Indica c tions i n c paci c ties

PFT Interpretation and Reference Values

PULMONARY FUNCTION TESTING. Purposes of Pulmonary Tests. General Categories of Lung Diseases. Types of PF Tests

EasyGuide Operator s Manual EasyOne Spirometer

Spirometry. Obstruction. By Helen Grim M.S. RRT. loop will have concave appearance. Flows decreased consistent with degree of obstruction.

SPIROMETRY METHOD. COR-MAN IN / EN Issue A, Rev INNOVISION ApS Skovvænget 2 DK-5620 Glamsbjerg Denmark

Coexistence of confirmed obstruction in spirometry and restriction in body plethysmography, e.g.: COPD + pulmonary fibrosis

What do pulmonary function tests tell you?

Physiology lab (RS) First : Spirometry. ** Objectives :-

Easy on-pc Operator's Manual

Teacher : Dorota Marczuk Krynicka, MD., PhD. Coll. Anatomicum, Święcicki Street no. 6, Dept. of Physiology

6- Lung Volumes and Pulmonary Function Tests

Interpreting pulmonary function tests: Recognize the pattern, and the diagnosis will follow

EasyGuide. EasyOne Spirometer. ndd Medizintechnik AG Technoparkstrasse 1 CH-8005 Zurich, Switzerland EU_EN_V50.

PULMONARY FUNCTION TEST(PFT)

Quality Assurance Mapping Your QC Program Equipment and Test Quality. Susan Blonshine RRT, RPFT, FAARC, AE-C

The role of lung function testing in the assessment of and treatment of: AIRWAYS DISEASE

Pulmonary Function Testing

Spirodoc. 3D Laboratory for respiratory analysis two functional modes: doctor and patient. Four devices in one. Spirometer with Touch Screen display

PC Based and Handheld Spirometers

2.0 Scope: This document is to be used by the DCS staff when collecting participants spirometry measurements using the TruFlow Easy-On Spirometer.

SPIROMETRY. Marijke Currie (CRFS) Care Medical Ltd Phone: Copyright CARE Medical ltd

PULMONARY FUNCTION TEST IN OBESE AND NON-OBESE INDIVIDUALS. 1 Dr. Shah Bijal, 2 Dr. Selot Bhavna, 3 Dr. Patel Sangita V., 4 Dr. Patel Nikhil J.

PULMONARY FUNCTION TESTING. By: Gh. Pouryaghoub. MD Center for Research on Occupational Diseases (CROD) Tehran University of Medical Sciences (TUMS)

Pulmonary Function Testing

Pulmonary Function Testing. Ramez Sunna MD, FCCP

Assessment of the Lung in Primary Care

Lung Pathophysiology & PFTs

Using Spirometry to Rule Out Restriction in Patients with Concomitant Low Forced Vital Capacity and Obstructive Pattern

PULMONARY FUNCTION TESTS

PFTs ACOI Board Review 2018

PULMONARY FUNCTION. VOLUMES AND CAPACITIES

Understanding the Basics of Spirometry It s not just about yelling blow

Improving Asthma and. Management with Spirometry 360

MSRC AIR Course Karla Stoermer Grossman, MSA, BSN, RN, AE-C

English. Innovation in Spirometry Oximetry Telemedicine

Purpose Of This Guide

Essen%als of Spirometry and Assessment

Clinical pulmonary physiology. How to report lung function tests

3 operating modes: Primary Care, Occupational Health or Diagnostic. Transducers: Turbine, Disposable or Fleisch. Spirometry quality control program.

Synergy Respiratory Care Dr. Lyle Melenka

Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene

Josh Stanton and Michael Epton Respiratory Physiology Laboratory, Canterbury Respiratory Research Group Christchurch Hospital

In order to diagnose lung diseases doctors

MasterLab. Individuality and Sophistication. - 6)

2.0 Scope: This document is to be used by the DCS staff when collecting participants spirometry measurements using the TruFlow Easy-On Spirometer.

Getting Spirometry Right It Matters! Performance, Quality Assessment, and Interpretation. Susan Blonshine RRT, RPFT, AE-C, FAARC

Basic approach to PFT interpretation. Dr. Giulio Dominelli BSc, MD, FRCPC Kelowna Respiratory and Allergy Clinic

Anyone who smokes and/or has shortness of breath and sputum production could have COPD

Asthma Assessment & Review

MASTER SYLLABUS C. Course Number and Title: RESP 2410 Respiratory Care Equipment/Procedures IV

Chapter 3. Pulmonary Function Study Assessments. Mosby items and derived items 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.

behaviour are out of scope of the present review.

Katrina M Hynes, MHA RRT RPFT Supervisor - Mayo Clinic Pulmonary Function Laboratory AARC Diagnostic Chair

RESPIRATORY PHYSIOLOGY Pre-Lab Guide

Lung function testing

Approach to CPET. CPET Cases. Case 1 4/4/2018. Impaired? Cardiac factors? Ventilatory factors?

Spirometry: an essential clinical measurement

Pulmonary Func-on Tes-ng. Chapter 8

REQUISITION FOR DIAGNOSTIC SERVICES

Office Spirometry Guide

Supplementary Online Content

Vitalograph Alpha Spirometer

WORKSHOP OF LUNG FUNCTION TEST. Dr. Lo Iek Long, Department of Respiratory Medicine, CHCSJ, Macau

The role of Pulmonary function Testing In Interstitial lung disease in infants. [ ipft in child ]

DLCO Webinar Q&A Dr. Christine Oropez answers post-presentation FAQs

BiomedicalInstrumentation

Accurately Measuring Airway Resistance in the PFT Lab

Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects

DESIGN, ANALYSIS AND IMPLEMENTATION OF SPIROMETER

DLCO versus DLCO/VA as predictors of pulmonary gas exchange $

Niche News August 2017 August 2017

Lung Function of Male Metropolitan Fire Fighters compared to General Population Controls

S P I R O M E T R Y. Objectives. Objectives 3/12/2018

The 2017 GOLD «approach» Margherita

Lung function in HIV infected adolescents on antiretroviral therapy in Cape Town, South Africa

Pulmonary Function Study

19 LUNG FUNCTION USING NDD EASY ON-PC

Joint Session ACOFP and AOASM: Exercise Induced Asthma. Bruce Dubin, DO, JD, FCLM, FACOI

PREDICTION EQUATIONS FOR PULMONARY DIFFUSING CAPACITY FOR NITRIC OXIDE IN HEALTHY AFRICAN- AMERICAN ADULTS

Comparative Study on Changes in Spirometric Lung Function Indices of Cobblestone Workers

Exercise 7: Respiratory System Mechanics: Activity 1: Measuring Respiratory Volumes and Calculating Capacities Lab Report

Spirometry Workshop for Primary Care Nurse Practitioners

Pulmonary Function Tests. Mohammad Babai M.D Occupational Medicine Specialist

Pulmonary Function Testing The Basics of Interpretation

Attachment 3 Revised Operation Manual

S P I R O M E T R Y. Objectives. Objectives 2/5/2019

Triennial Pulmonary Workshop 2012

Objectives. Pulmonary Assessment 12/13/2017

Innovation in Spirometry Oximetry Telemedicine. MIR Software.

Bronchial Provocation Results: What Does It Mean?

Clinical Study Bronchial Responsiveness in Patients with Restrictive Spirometry

Respiratory Physiology In-Lab Guide

$1,095 ECO GET VITAL APP Scan Here

TECHNOLOGY - INNOVATION IN ULTRASONIC RESPIRATORY DIAGNOSTICS. Otthon. Ultrasonic handheld spirometer

Spirometry and Flow Volume Measurements

#7 - Respiratory System

Credential Maintenance Program

Vitalograph Products and Services Guide

Breathing and pulmonary function

Transcription:

Report Templates Available for EasyOne Pro (LAB) and Easy onpc Contents 1 Introduction... 1 2 Standard Report Templates... 2 2.1 FVC/FVL, Standard... 2 2.2 FVC, Large... 3 2.3 FVC/FVL, Large... 4 2.4 FVC/FVL, Large FV Only... 5 2.5 MVV... 6 2.6 SVC... 7 2.7 DLCO... 8 2.8 Summary... 9 2.9 Summary 2 pages... 10 2.10 Provocation... 11 3 Additional Report Templates... 12 3.1 Forced Spiro shows Fletcher always... 12 3.2 DLCO Quality off... 13 3.3 DLCO without graphics... 14 3.4 FRC Detail Report... 15 3.5 Summary 3 Curves... 16 3.6 Summary Best 3 Trial... 17 3.7 Summary with Fletcher... 18 3.8 Summary with MVV... 19 3.9 Summary no Quality, no Interpretation... 20 3.10 Summary no Interpretation... 21 3.11 Summary 2P Quality off, Interpretation off... 22 3.12 Summary 2P (Patientinfo on each page)... 23 1 Introduction The software for Easy onpc and EasyOne Pro (LAB) is by default equipped with a large number of Standard Report Templates. Additional Report Templates, however, are available for download from ndd s web site: http://www.ndd.ch/downloads/software.aspx This application note shows examples of all default reports (Chapter 2) and additional examples of reports that are available for download (Chapter 3). DLCO reports are for protocols from EasyOne Pro (LAB) and FRC reports are only for EasyOne Pro LAB protocols. ndd Medizintechnik AG, 112013, TKA, MZ 1 / 23 AppNoteavailable ReportTemplatesV03R.docx

2 Standard Report Templates 2.1 FVC/FVL, Standard ndd Medizintechnik AG, 112013, TKA, MZ 2 / 23 AppNoteavailable ReportTemplatesV03R.docx

2.2 FVC, Large ndd Medizintechnik AG, 112013, TKA, MZ 3 / 23 AppNoteavailable ReportTemplatesV03R.docx

2.3 FVC/FVL, Large ndd Medizintechnik AG, 112013, TKA, MZ 4 / 23 AppNoteavailable ReportTemplatesV03R.docx

2.4 FVC/FVL, Large FV Only ndd Medizintechnik AG, 112013, TKA, MZ 5 / 23 AppNoteavailable ReportTemplatesV03R.docx

2.5 MVV ndd Medizintechnik AG, 112013, TKA, MZ 6 / 23 AppNoteavailable ReportTemplatesV03R.docx

2.6 SVC ndd Medical Technologies Zurich, Switzerland Patient Information Name Smith, Peter ID PSM11213 Age 40 (08.11.1968) Height 182 cm Weight 80 kg BMI 24.2 Gender Male Ethnicity Caucasian Smoker No Test Information Test Type Test Date Post Time Interpretation Predicted Value Selection BTPS (IN/EX) SVC 21.04.2009 17:49:05 GOLD(2003)/Hardie NHANES III Best Value 1.10/1.02 Test Result Parameter VC [L] VCex [L] VCin [L] IRV [L] IC [L] VT [L] Rf [1/min] Session Quality Pred 5.58 5.58 Pre Pre LLN Best Trial 2 Trial 1 4.60 5.32 5.32 5.31 5.32 5.32 5.31 3.15 2.80 3.21 3.90 3.72 3.84 0.75 0.92 0.63 17.7 17.7 16.7 A (VC Var=0.01L (0.1%)) Trial 3 5.08 5.08 3.45 4.15 0.70 16.8 %Pred 95 ndd Medizintechnik AG Easy onpc [1.7.6.4/01.01.00.9999] (en) / EasyOnePro [4.3.7.27] SN EOP500011/11568 1/1 nddreportsvc ndd Medizintechnik AG, 112013, TKA, MZ 7 / 23 AppNoteavailable ReportTemplatesV03R.docx

2.7 DLCO ndd Medizintechnik AG, 112013, TKA, MZ 8 / 23 AppNoteavailable ReportTemplatesV03R.docx

2.8 Summary ndd Medical Technologies Zurich, Switzerland Patient Information Name Smith, Peter Gender Male ID PSM11213 Ethnicity Caucasian Age 40 (08.11.1968) Asthma Yes Height 182 cm Weight 80 kg BMI 24.2 Smoker FVC (ex only) No Your FEV1 / Predicted: 91% Predicted Test Date Post Time NHANES III 21.04.2009 18:43 Pre Parameter Pred LLN Best %Pred FVC [L] 5.58 4.60 5.30 95 FEV1 [L] 4.43 3.60 4.02 91 FEV1/FVC 0.798 0.701 0.759 95 FEF2575% [L/s] 4.13 2.46 3.19 77 PEF [L/s] 10.55 8.12 11.82 112 FET [s] 6.5 Session Quality Pre A (FEV1 Var=0.06L (1.6%); FVC Var=0.01L (0.1%)) System Interpretation Pre Normal Spirometry DLCO Predicted Test Date SVC Predicted Test Date NHANES 21.04.2009 18:20 NHANES III 21.04.2009 17:49 Pre Parameter Pred LLN Result %Pred Parameter Pred LLN Best %Pred DLCO [ml/min/mmhg] 36.8 26.6 39.1 106 VC [L] 5.58 4.60 5.32 95 DLadj [ml/min/mmhg] 36.8 26.6 39.2 106 VCex [L] 5.32 VA sb [L] 6.30 VCin [L] 5.58 DLCO/VA (KCO) 6.21 IRV [L] 3.15 [ml/min/mmhg/l] IC [L] 3.90 TLC sb [L] 7.35 6.35 6.45 88 VT [L] 0.75 VI [L] 5.58 5.22 94 Session Quality Pre A (VC Var=0.01L (0.1%)) Session Quality A (DLCO Var=1.84ml/min/mmHg (4.6%)) ndd Medizintechnik AG Easy onpc [1.7.6.4/01.01.00.9999] (en) / EasyOnePro [4.3.7.27] SN EOP500011/11568 1/1 nddreportsummary ndd Medizintechnik AG, 112013, TKA, MZ 9 / 23 AppNoteavailable ReportTemplatesV03R.docx

2.9 Summary 2 pages ndd Medizintechnik AG, 112013, TKA, MZ 10 / 23 AppNoteavailable ReportTemplatesV03R.docx

2.10 Provocation ndd Medizintechnik AG, 112013, TKA, MZ 11 / 23 AppNoteavailable ReportTemplatesV03R.docx

3 3.1 Additional Report Templates Forced Spiro shows Fletcher always ndd Medizintechnik AG, 112013, TKA, MZ 12 / 23 AppNoteavailable ReportTemplatesV03R.docx

3.2 DLCO Quality off ndd Medizintechnik AG, 112013, TKA, MZ 13 / 23 AppNoteavailable ReportTemplatesV03R.docx

3.3 DLCO without graphics ndd Medizintechnik AG, 112013, TKA, MZ 14 / 23 AppNoteavailable ReportTemplatesV03R.docx

3.4 FRC Detail Report ndd Medizintechnik AG, 112013, TKA, MZ 15 / 23 AppNoteavailable ReportTemplatesV03R.docx

3.5 Summary 3 Curves ndd Medical Technologies Zurich, Switzerland Patient Information Name Smith, Peter ID PSM11213 Age 40 (08.11.1968) Height 182 cm Weight 80 kg BMI 24.2 Gender Ethnicity Smoker Asthma Male Caucasian No Yes FVL Tidal Your FEV1 / Predicted: 91% Predicted Test Date Post Time NHANES III 21.04.2009 18:17 21.04.2009 18:37 Pre Post Parameter Pred LLN Best %Pred Best %Pred %Chg FVC [L] 5.58 4.60 5.21 93 5.25 94 1 FEV1 [L] 4.43 3.60 4.02 91 4.02 91 0 FEV1/FVC 0.798 0.701 0.771 97 0.766 96 1 FEF2575% [L/s] 4.13 2.46 3.32 81 3.28 79 1 PEF [L/s] 10.55 8.12 11.75 111 11.56 110 2 FET [s] 4.2 5.4 27 Session Quality Pre A (FEV1 Var=0.05L (1.4%); FVC Var=0.01L (0.1%)) Post A (FEV1 Var=0.05L (1.2%); FVC Var=0.01L (0.1%)) System Interpretation Pre Normal Spirometry Post Normal Spirometry DLCO Predicted Test Date SVC Predicted Test Date NHANES 21.04.2009 18:20 NHANES III 21.04.2009 17:49 Pre Parameter Pred LLN Result %Pred Parameter Pred LLN Best %Pred DLCO [ml/min/mmhg] 36.8 26.6 39.1 106 VC [L] 5.58 4.60 5.32 95 TLC sb [L] 7.35 6.35 6.45 88 VCex [L] 5.32 Session Quality A (DLCO Var=1.84ml/min/mmHg (4.6%)) VCin [L] 5.58 IRV [L] 3.15 IC [L] 3.90 VT [L] 0.75 Session Quality Pre A (VC Var=0.01L (0.1%)) ndd Medizintechnik AG Easy onpc [1.3.5.0/01.01.00.9999] (en) / EasyOnePro [4.3.7.27] SN EOP500011/11568 1/1 Custom report Summary 3 Curves ndd Medizintechnik AG, 112013, TKA, MZ 16 / 23 AppNoteavailable ReportTemplatesV03R.docx

3.6 Summary Best 3 Trial ndd Medizintechnik AG, 112013, TKA, MZ 17 / 23 AppNoteavailable ReportTemplatesV03R.docx

3.7 Summary with Fletcher ndd Medizintechnik AG, 112013, TKA, MZ 18 / 23 AppNoteavailable ReportTemplatesV03R.docx

3.8 Summary with MVV ndd Medizintechnik AG, 112013, TKA, MZ 19 / 23 AppNoteavailable ReportTemplatesV03R.docx

3.9 Summary no Quality, no Interpretation ndd Medical Technologies Zurich, Switzerland Patient Information Name Smith, Peter ID PSM11213 Age 40 (08.11.1968) Height 182 cm Weight 80 kg BMI 24.2 Gender Ethnicity Smoker Asthma Male Caucasian No Yes FVL Tidal Your FEV1 / Predicted: 91% Predicted Test Date Post Time NHANES III 21.04.2009 18:17 21.04.2009 18:37 Pre Post Parameter Pred LLN Best %Pred Best %Pred %Chg FVC [L] 5.58 4.60 5.21 93 5.25 94 1 FEV1 [L] 4.43 3.60 4.02 91 4.02 91 0 FEV1/FVC 0.798 0.701 0.771 97 0.766 96 1 FEF2575% [L/s] 4.13 2.46 3.32 81 3.28 79 1 PEF [L/s] 10.55 8.12 11.75 111 11.56 110 2 FET [s] 4.2 5.4 27 DLCO Predicted NHANES Test Date 21.04.2009 18:20 SVC Predicted NHANES III Parameter Pred LLN Result %Pred Parameter Pred DLCO [ml/min/mmhg] 36.8 26.6 39.1 106 VC [L] 5.58 TLC sb [L] 7.35 6.35 6.45 88 VCex [L] VCin [L] 5.58 IRV [L] IC [L] VT [L] LLN 4.60 Test Date 21.04.2009 17:49 Pre Best %Pred 5.32 95 5.32 3.15 3.90 0.75 ndd Medizintechnik AG Easy onpc [1.3.5.0/01.01.00.9999] (en) / EasyOnePro [4.3.7.27] SN EOP500011/11568 1/1 Custom report Summary no Quality, no Interpretation ndd Medizintechnik AG, 112013, TKA, MZ 20 / 23 AppNoteavailable ReportTemplatesV03R.docx

3.10 Summary no Interpretation ndd Medical Technologies Zurich, Switzerland Patient Information Name Smith, Peter ID PSM11213 Age 40 (08.11.1968) Height 182 cm Weight 80 kg BMI 24.2 Gender Ethnicity Smoker Asthma User ID FVL Tidal Your FEV1 / Predicted: 91% Parameter FVC [L] FEV1 [L] FEV1/FVC FEF2575% [L/s] PEF [L/s] FET [s] Session Quality Predicted NHANES III Pred 5.58 4.43 0.798 4.13 10.55 Pre Post Test Date 21.04.2009 18:17 Post Time 21.04.2009 18:37 Pre Post LLN Best %Pred Best %Pred %Chg 4.60 5.21 93 5.25 94 1 3.60 4.02 91 4.02 91 0 0.701 0.771 97 0.766 96 1 2.46 3.32 81 3.28 79 1 8.12 11.75 111 11.56 110 2 4.2 5.4 27 A (FEV1 Var=0.05L (1.4%); FVC Var=0.01L (0.1%)) A (FEV1 Var=0.05L (1.2%); FVC Var=0.01L (0.1%)) Male Caucasian No Yes DLCO Predicted Test Date SVC Predicted Test Date NHANES 21.04.2009 18:20 NHANES III 21.04.2009 17:49 Pre Parameter Pred LLN Result %Pred Parameter Pred LLN Best %Pred DLCO [ml/min/mmhg] 36.8 26.6 39.1 106 VC [L] 5.58 4.60 5.32 95 TLC sb [L] 7.35 6.35 6.45 88 VCex [L] 5.32 Session Quality A (DLCO Var=1.84ml/min/mmHg (4.6%)) VCin [L] 5.58 IRV [L] 3.15 IC [L] 3.90 VT [L] 0.75 Session Quality Pre A (VC Var=0.01L (0.1%)) ndd Medizintechnik AG Easy onpc [1.3.5.0/01.01.00.9999] (en) / EasyOnePro [4.3.7.27] SN EOP500011/11568 1/1 Custom report Summary no Interpretation ndd Medizintechnik AG, 112013, TKA, MZ 21 / 23 AppNoteavailable ReportTemplatesV03R.docx

3.11 Summary 2P Quality off, Interpretation off ndd Medizintechnik AG, 112013, TKA, MZ 22 / 23 AppNoteavailable ReportTemplatesV03R.docx

3.12 Summary 2P (Patientinfo on each page) ndd Medizintechnik AG, 112013, TKA, MZ 23 / 23 AppNoteavailable ReportTemplatesV03R.docx

2024 © healthdocbox.com Privacy Policy | Terms of Service | Feedback